ViaSat, Inc. (Nasdaq: VSAT) has made a public offering of 2,271,500 shares of common stock at a price to the public of $30 per share. All of the 2,271,500 shares were offered by ViaSat.

The managing underwriters of the offering are Merrill Lynch & Co., ING Barings, C.E. Unterberg Towbin, CIBC World Markets and Gerard Klauer Mattison & Co. ViaSat has granted the underwriters an option to purchase up to 340,725 additional shares of common stock to cover over-allotments, if any.

ViaSat anticipates that it will use the net proceeds of the offering to fund the previously announced acquisition of the satellite networks business of Scientific-Atlanta.

Copies of the final prospectus for the offering may be obtained from Merrill Lynch & Co. at World Financial Center, 250 Vesey Street, 2nd Floor, New York, New York 10281, Attn: Prospectus Department, 212-449-1000.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

Portions of this release may contain forward-looking statements regarding future events and are subject to risks and uncertainties. ViaSat wishes to caution you that there are some factors that could cause actual results to differ materially, including but not limited to: uncertainties relating to the consummation of the acquisition of the satellite networks business; inability to raise sufficient capital for continued expansion and operation; technologies not being developed according to anticipated schedules, or that do not perform according to expectations; and increased competition and other factors affecting the telecommunications industry generally. ViaSat refers you to the documents it files from time to time with the Securities and Exchange Commission, specifically the section titled Risk Factors in ViaSat's Form 10-K, which contain and identify other important factors that could cause actual results to differ materially from those contained in our projections or forward-looking statements.

« Back to news archive